Efficacy, tolerability, and endometrial safety of ospemifene compared with current therapies for the treatment of vulvovaginal atrophy: a systematic literature review and network meta-analysis. [PDF]
Simon JA +6 more
europepmc +1 more source
Effects of Non-Ablative Solid-State Vaginal Laser (SSVL) for the Treatment of Vulvovaginal Atrophy in Breast Cancer Survivors after Adjuvant Aromatase Inhibitor Therapy: Preliminary Results. [PDF]
Lubián-López DM +6 more
europepmc +1 more source
Vaginal hormone-free moisturising cream is not inferior to an estriol cream for treating symptoms of vulvovaginal atrophy: Prospective, randomised study. [PDF]
Garcia de Arriba S +5 more
europepmc +1 more source
Clinical Efficacy of Hormonal and Nonhormonal Agents in the Treatment of Vulvovaginal Atrophy. [PDF]
Ilhan G +4 more
europepmc +1 more source
The evidence behind the use of LASER for genitourinary syndrome of menopause, vulvovaginal atrophy, urinary incontinence and lichen sclerosus: A state-of-the-art review. [PDF]
Mortensen OE +2 more
europepmc +1 more source
Case series on the effect of ayurvedic medications in the management of symptoms of vulvovaginal atrophy in postmenopausal women. [PDF]
Surendran ES, Balakrishnan P, Raj LS.
europepmc +1 more source
An Open, Uncontrolled Pilot Study on 12-Week Use of VagiVital for Treatment of Vulvovaginal Atrophy in Breast Cancer Patients Undergoing Adjuvant Aromatase-Inhibitor Therapy. [PDF]
Jonasson AF, Åstrom M.
europepmc +1 more source
Value of injection of plasma-rich platelets in the vaginal mucosa in cases with vulvovaginal atrophy: a prospective double-blinded randomized controlled study. [PDF]
Hamid ASA +4 more
europepmc +1 more source
Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up. [PDF]
Veron L +7 more
europepmc +1 more source
Effectiveness of Erbium: YAG Laser in the Treatment of Vulvovaginal Atrophy in Women Who Survived Breast Cancer. [PDF]
Ferreira KST +6 more
europepmc +1 more source

